HKSE:09886 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:09886 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Dingdang Health Technology Group's share price is HK$0.51. Dingdang Health Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.98. Hence, Dingdang Health Technology Group's PS Ratio for today is 0.13.
Good Sign:
Dingdang Health Technology Group Ltd stock PS Ratio (=0.11) is close to 3-year low of 0.11
The historical rank and industry rank for Dingdang Health Technology Group's PS Ratio or its related term are showing as below:
During the past 6 years, Dingdang Health Technology Group's highest PS Ratio was 3.65. The lowest was 0.11. And the median was 0.44.
Dingdang Health Technology Group's Revenue per Sharefor the six months ended in Dec. 2023 was HK$2.14. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.98.
Warning Sign:
Dingdang Health Technology Group Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Dingdang Health Technology Group was -31.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 26.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 58.00% per year.
During the past 6 years, Dingdang Health Technology Group's highest 3-Year average Revenue per Share Growth Rate was 89.30% per year. The lowest was 26.30% per year. And the median was 75.80% per year.
The historical data trend for Dingdang Health Technology Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
PS Ratio | Get a 7-Day Free Trial | - | - | - | 2.03 | 0.50 |
Dingdang Health Technology Group Semi-Annual Data | ||||||||||
Dec18 | Dec19 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
PS Ratio | Get a 7-Day Free Trial | - | 2.03 | - | 0.50 | - |
For the Health Information Services subindustry, Dingdang Health Technology Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Dingdang Health Technology Group's PS Ratio for today is calculated as
PS Ratio | = | Share Price | / | Revenue per Share (TTM) |
= | 0.51 | / | 3.982 | |
= | 0.13 |
Dingdang Health Technology Group's Share Price of today is HK$0.51.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dingdang Health Technology Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.98.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PS Ratio | = | Market Cap | / | Revenue |
The Revenue here is for the trailing 12 months.
Dingdang Health Technology Group (HKSE:09886) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.
Be Aware
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Thank you for viewing the detailed overview of Dingdang Health Technology Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Yang Yibin | 2201 Interest of corporation controlled by you | |
Tpg Operating Group Iii, L.p. | 2201 Interest of corporation controlled by you | |
Tpg Inc. | 2201 Interest of corporation controlled by you | |
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Zhao Yin Guo Ji Jin Rong You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si | 2201 Interest of corporation controlled by you | |
Xing Xin You Xian Gong Si | ||
Jian Xing You Xian Gong Si | ||
Zhi Ying Ji Tuan You Xian Gong Si | ||
Jian Fa You Xian Gong Si | ||
Jin Fa You Xian Gong Si | ||
Zhi Sheng Qi Ye You Xian Gong Si | ||
Chuang Ji Tou Zi You Xian Gong Si |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.